A landmark IPO always raises big questions — and SpaceX is no exception. Reuters takes a closer look at what comes next for the newly listed space giant, from valuation pressures to Starlink’s growth path and the strategic challenges ahead. A thoughtful read featuring expert insights, including those of Ismael García Puente. Read more here: Wall Street ends higher as SpaceX's market debut dominates | Reuters More coverage below: Investor Daily https://www.investordaily.com.au

As the SpaceX IPO continues to spark global market debate, Crowdfund Insider brings together fintech and investment commentators to assess what this listing could mean for public markets, innovation, and investor appetite. Sean Peche, Portfolio Manager at Ranmore Fund Management, draws a parallel to purchasing Pfizer shares in April of 1998. Bloomberg indicates the total return would have been a negative 26% over 28 years. Read more here: Fintech Observers Comment On SpaceX I